Tuesday, 12 June 2012

Etravirine


Pronunciation: E-tra-VIR-een
Generic Name: Etravirine
Brand Name: Intelence


Etravirine is used for:

Treating HIV infection in certain patients. It is used in combination with other medicines.


Etravirine is a nonnucleoside reverse transcriptase inhibitor (NNRTI). It works by blocking the growth of HIV.


Do NOT use Etravirine if:


  • you are allergic to any ingredient in Etravirine

  • you are taking another NNRTI (eg, efavirenz)

  • you are taking certain protease inhibitors (eg, indinavir) without ritonavir

  • you are taking delavirdine, certain doses of ritonavir, or certain protease inhibitor and ritonavir combinations (eg, tipranavir/ritonavir, atazanavir/ritonavir)

  • you are taking a barbiturate (eg, phenobarbital), carbamazepine, a hydantoin (eg, phenytoin), rifampin, rifapentine, or St. John's wort

Contact your doctor or health care provider right away if any of these apply to you.



Before using Etravirine:


Some medical conditions may interact with Etravirine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you are of childbearing age

  • if you have a history of liver problems (eg, hepatitis), diabetes, or high blood cholesterol

Some MEDICINES MAY INTERACT with Etravirine. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Delavirdine because it may increase the risk of Etravirine's side effects

  • Barbiturates (eg, phenobarbital), carbamazepine, hydantoins (eg, phenytoin), other NNRTIs (eg, efavirenz), protease inhibitor and ritonavir combinations (eg, tipranavir/ritonavir), protease inhibitors (eg, indinavir), rifamycins (eg, rifampin, rifapentine), certain doses of ritonavir, or St. John's wort because they may decrease Etravirine's effectiveness

  • Atazanavir/ritonavir because its effectiveness may be decreased by Etravirine and it may increase the risk of Etravirine's side effects

  • Fosamprenavir/ritonavir because the risk of its side effects may be increased by Etravirine

  • Many prescription and nonprescription medicines (eg, used for anxiety, erectile problems, irregular heartbeat, other heart problems, bacterial infections, fungal infections, immune suppression, inflammation, aches and pains, high cholesterol, HIV, narcotic or other substance dependence and withdrawal, seizures, thinning the blood), multivitamin products, and herbal or dietary supplements (eg, herbal teas, coenzyme Q10, garlic, ginseng, ginkgo, St. John's wort) may interact with Etravirine. This may decrease their effectiveness, increase the risk of their side effects, decrease Etravirine's effectiveness, or increase the risk of the medicine's side effects

This may not be a complete list of all interactions that may occur. Ask your health care provider if Etravirine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Etravirine:


Use Etravirine as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Etravirine. Talk to your pharmacist if you have questions about this information.

  • Take Etravirine by mouth following a meal.

  • Swallow Etravirine whole with a liquid such as water. Do not chew before swallowing. If you cannot swallow the tablet whole, you may mix it in a glass of water. Stir well until the water looks milky, and then drink all of the liquid right away. Rinse the glass with water several times and completely swallow the rinse each time to ensure the entire dose is taken. Do not store the mixture for future use.

  • Taking Etravirine at the same time each day will help you remember to take it.

  • Continue to use Etravirine even if you feel well. Do not miss any doses.

  • If you miss a dose of Etravirine by less than 6 hours, take the missed dose as soon as possible following a meal, then go back to your regular dosing schedule. If you miss your dose by more than 6 hours, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Etravirine.



Important safety information:


  • Etravirine may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Etravirine with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not change your dose or stop taking Etravirine without talking to your doctor first.

  • Etravirine is not a cure for HIV infection. Patients may still get illnesses and infections associated with HIV. Remain under the care of your doctor.

  • When your medicine supply is low, get more from your doctor or pharmacist as soon as you can. Do not stop taking Etravirine, even for a short period of time. If you do, the virus may grow resistant to the medicine and become harder to treat.

  • Etravirine does not stop the spread of HIV to others through blood or sexual contact. Use barrier methods of birth control (eg, condoms) if you have HIV infection. Do not share needles, injection supplies, or items like toothbrushes or razors.

  • Changes in body fat (eg, an increased amount of fat in the upper back, neck, breast, and trunk, and loss of fat from the legs, arms, and face) may occur in some patients taking Etravirine. The cause and long-term effects of these changes are unknown. Discuss any concerns with your doctor.

  • Etravirine may improve immune system function. This may reveal hidden infections in some patients. Tell your doctor right away if you notice symptoms of infection (eg, fever, sore throat, weakness, cough, shortness of breath) after you start Etravirine.

  • Etravirine may cause serious, potentially life-threatening, and fatal skin reactions. The risk may be greater in women. Symptoms may include red, swollen, blistered, or peeling skin; severe rash or rash with fever, mouth sores, red and irritated eyes, or swelling of the face; muscle or joint pain; unusual tiredness; or unusual hoarseness. These reactions can sometimes be associated with organ failure (eg, liver failure). Contact your doctor at once if you develop a rash or any of these symptoms.

  • Lab tests, including liver function, CD4 count, complete blood cell counts, and blood cholesterol, may be performed while you use Etravirine. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Etravirine should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Etravirine while you are pregnant. It is not known if Etravirine is found in breast milk. Mothers infected with HIV should not breast-feed. There is a risk of passing HIV infection or Etravirine to the baby.


Possible side effects of Etravirine:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Mild burning, numbness, or tingling of the arms, hands, legs, or feet.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the eyes, mouth, face, lips, throat, or tongue; unusual hoarseness); bloody vomit or vomit that looks like coffee grounds; blurred vision or other vision changes; change in amount of urine; chest, jaw, or left arm pain; dark urine; fainting; fever or general feeling of being unwell; irregular heartbeat; joint pain; loss of appetite; mood or mental changes (eg, anxiety, confusion, memory loss); muscle pain, tenderness, or weakness; pale stools; persistent burning, numbness, pain, or tingling of the arms, legs, hands, or feet; reddened, blistered, swollen, or peeling skin; seizures; severe or persistent dizziness, drowsiness, or headache; severe rash or rash with fever, mouth sores, or red and irritated eyes; severe stomach pain with or without nausea and vomiting; shortness of breath; unusual tiredness or weakness; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Etravirine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Etravirine:

Store Etravirine between 59 and 86 degrees F (15 and 30 degrees C). Store in original bottle, away from heat, moisture, and light. Do not remove the desiccant pouches from the bottle. Do not store in the bathroom. Keep Etravirine out of the reach of children and away from pets.


General information:


  • If you have any questions about Etravirine, please talk with your doctor, pharmacist, or other health care provider.

  • Etravirine is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Etravirine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Etravirine resources


  • Etravirine Side Effects (in more detail)
  • Etravirine Use in Pregnancy & Breastfeeding
  • Etravirine Drug Interactions
  • Etravirine Support Group
  • 0 Reviews for Etravirine - Add your own review/rating


  • Etravirine Professional Patient Advice (Wolters Kluwer)

  • Etravirine Monograph (AHFS DI)

  • etravirine Advanced Consumer (Micromedex) - Includes Dosage Information

  • Intelence Prescribing Information (FDA)

  • Intelence Consumer Overview



Compare Etravirine with other medications


  • HIV Infection

No comments:

Post a Comment